Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_16-cv-01182/USCOURTS-cand-3_16-cv-01182-0/pdf.json

Parties Involved:
Thomas Brownfield
Plaintiff
Pfizer, Inc.
Defendant

Document Text:

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1 

STIPULATION AND [PROPOSED] ORDER 

3:16-cv-01182-RS 

Matthew A. Holian (SBN 211728) 

DLA Piper LLP (US) 

33 Arch Street, 26th floor 

Boston, MA 02110-1447 

Telephone: (617) 406-6009 

Facsimile: (617) 406-6109 

Email: Matt.Holian@dlapiper.com

George J. Gigounas (SBN 209334) 

DLA Piper LLP (US) 

555 Mission Street, Suite 2400 

San Francisco, CA 94105-2933 

Telephone: (415) 615-6005 

Facsimile: (415) 659-7305 

Email: George.Gigounas@dlapiper.com

Attorneys for Defendant 

Pfizer Inc. 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

SAN FRANCISCO DIVISION 

THOMAS BROWNFIELD, 

 Plaintiff, 

v. 

PFIZER, INC. 

Defendant. 

 Case No.: 3:16-cv-01182-RS 

STIPULATION AND [PROPOSED] 

ORDER CONTINUING DEADLINE TO 

RESPOND TO COMPLAINT 

Case 3:16-cv-01182-RS Document 11 Filed 03/23/16 Page 1 of 5
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

2 

STIPULATION AND [PROPOSED] ORDER 

3:16-cv-01182-RS 

On December 11, 2015, several Plaintiffs, without opposition, moved the Judicial Panel 

on Multidistrict Litigation (“JPML”) to transfer and coordinate 15 actions, including any “tagalong” actions, in the United States District Court for the Northern District of California, 

pursuant to 28 U.S.C. §1407. Defendants agree that coordination is appropriate and that the 

Northern District of California is a suitable venue. See Case MDL No. 2691, Dkt. 1 through 1-4. 

On December 28, 2015, with briefing essentially complete in support of Plaintiffs’ 

unopposed motion to transfer, the parties jointly moved the JPML for expedited consideration of 

Plaintiffs’ unopposed motion on the January 28, 2016 hearing session. See Case MDL No. 2691, 

Dkt. 16. 

On December 29, 2015, the motion for expedited consideration was denied by the JPML. 

See Case MDL No. 2691, Dkt. 19. Plaintiffs’ motion to transfer will be heard at the next JPML 

hearing, on March 31, 2016 in Santa Barbara. 

Defendant Pfizer Inc.’s current deadline to respond to the complaint in this matter is 

April 5, 2016. The parties have not previously requested an extension of time for any deadlines 

in this matter. 

To avoid unnecessary pleadings and provide the JPML with the time it requires to rule on 

the parties’ pending motion to transfer, Defendant Pfizer Inc. and Plaintiff Thomas Brownfield 

wish to stipulate to extend Pfizer’s deadline to respond to the Complaint until sixty (60) days 

after a ruling by the JPML on Plaintiffs’ motion to transfer. 

Based on the foregoing and pursuant to Civil L.R. 6-2 of the Northern District of 

California, the parties stipulate and agree to extend Pfizer’s deadline to respond to Plaintiff’s 

complaint in this matter until sixty (60) days after the JPML rules on Plaintiffs’ motion to 

transfer, described above. 

//// 

//// 

//// 

//// 

//// 

Case 3:16-cv-01182-RS Document 11 Filed 03/23/16 Page 2 of 5
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

3 

STIPULATION AND [PROPOSED] ORDER 

3:16-cv-01182-RS 

DATED: March 22, 2016 By:____/s/ Rachel B. Abrams ________ 

Rachel B. Abrams (SBN 209316) 

Meghan E. McCormick (SBN 283853) 

LEVIN SIMES LLP 

44 Montgomery Street, 32nd Floor 

San Francisco, CA 94104 

Telephone: (415) 426-3000 

Facsimile: (415) 426-3001 

Email: rabrams@levinsimes.com

Email: mmccormick@levinsimes.com

Ernest Cory 

Kristian W. Rasmussen 

Lauren S. Miller 

CORY WATSON, P.C. 

2131 Magnolia Avenue, Suite 200 

Birmingham, AL 35205 

Telephone: (205) 328-2200 

Facsimile: (205) 324-7896 

Email: ecory@corywatson.com

Email: krasmussen@corywatson.com

Email: lmiller@corywatson.com

Attorneys for Plaintiff 

DATED: March 22, 2016 By:____/s/ Matthew A. Holian_________________ 

Matthew A. Holian (SBN 211728) 

DLA PIPER LLP (US) 

33 Arch Street, 26th floor 

Boston, MA 02110 -1447 

Telephone: (617) 406-6009 

Facsimile: (617) 406-6109 

Email: Matt.Holian@dlapiper.com

George J. Gigounas (SBN 209334) 

DLA PIPER LLP (US) 

555 Mission Street Suite 2400 

San Francisco, California 94105-2933 

Telephone: (415) 615-6005 

Facsimile: (415) 659-7305 

Email: George.Gigounas@dlapiper.com

Attorneys for Pfizer Inc. 

Case 3:16-cv-01182-RS Document 11 Filed 03/23/16 Page 3 of 5
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

4 

STIPULATION AND [PROPOSED] ORDER 

3:16-cv-01182-RS 

I, Matthew A. Holian, am the ECF user whose identification and password are being used to file 

the foregoing Stipulation And [Proposed] Order Continuing Deadline To Respond To Complaint. 

I hereby attest that the above-referenced signatory to this stipulation has concurred in this filing. 

/s/ Matthew A. Holian 

MATTHEW A. HOLIAN 

Case 3:16-cv-01182-RS Document 11 Filed 03/23/16 Page 4 of 5
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

5 

STIPULATION AND [PROPOSED] ORDER 

3:16-cv-01182-RS 

ORDER 

PURSUANT TO STIPULATION OF THE PARTIES, IT IS ORDERED: 

The time for Defendant Pfizer Inc. to respond to Plaintiff’s complaint in this action is 

continued until sixty (60) calendar days after the Judicial Panel on Multidistrict Litigation 

(“JPML”) issues its ruling on Plaintiffs’ pending motion to transfer and coordinate 15 actions, 

including any “tag-along” actions, in the United States District Court for the Northern District of 

California, pursuant to 28 U.S.C. §1407. 

Dated: _________________, 2016 

By: 

Honorable Richard Seeborg 

United States District Court Judge 

3/23

Case 3:16-cv-01182-RS Document 11 Filed 03/23/16 Page 5 of 5